Human MCF-7 breast carcinoma cells possess a receptor-like moiety on their surface that has a high binding affinity (Kd = 2 nM) for laminin, a glycoprotein localized in basement membranes. Laminin preferentially stimulates (8-fold) MCF-7 cells to attach to type IV (basement membrane) collagen, whereas fibronectin stimulates attachment only 2-fold for these cells on type I collagen. The attachment properties of two other human breast carcinoma cell lines to type IV collagen were also studied. The attachment of ZR-75-1 cells was stimulated 4-fold by laminin and 5-fold by fibronectin, whereas T47-D cell attachment was stimulated 2-fold by laminin and 7-fold by fibronectin. By employing protease-derived fragments oflaminin, the major domains of the laminin molecule that participate in MCF-7 cell attachment to type IV collagen were identified. The whole laminin molecule has the configuration of a four-armed cross with three short arms and one long arm. A major cell-binding domain was found to reside near the intersection point of the short arms, and the type IV collagen-binding domain was associated with the globular end regions of the short arms. The receptor for laminin on the surface of these tumor cells may be involved in the initial interaction oftumor cells via laminin with the vascular basement membrane to facilitate invasion and subsequent promotion of metastasis.

The human laminin receptor was purified and molecularly cloned to investigate its biosynthetic regulation. Laminin receptor from normal and neoplastic tissue was preparatively affinity purified to homogeneity based on the high affinity of the receptor for laminin. The apparent molecular weight of the receptor from different carcinoma sources and from normal placental tissue is in the range of 68-72 kDa. Isoelectric focusing and two-dimensional gel electrophoresis indicated that the receptor protein consists of one major polypeptide chain with a pI value of 6.4 ± 0.2. Laminin receptor cDNA clones were isolated after screening a human endothelial Xgtll cDNA library with a monoclonal antibody directed against a domain of the laminin receptor involved in ligand binding. Definitive identification of the cDNA clones was based on comparison of cDNA sequence with the amino acid sequence of a cyanogen bromide-generated octapeptide of purified placental laminin receptor. The laminin receptor mRNA is approximately 1700 bases long. The level of laminin receptor mRNA in a variety of human carcinoma-derived cell lines correlated with the number of laminin receptors on the cell surfaces of those cells. This suggests that the amount of laminin receptor mRNA may be a rate-limiting control step in the biosynthesis of the laminin receptor, and hence in the regulation of cellular attachment to basement membranes via lamiin.Laminin, a high molecular weight glycoprotein, is a prominent component of basement membranes from all types of tissues. It appears to play a significant role in a variety of biologic phenomena including cell attachment, cell spreading, morphogenesis, differentiation, mitogenesis, neurite outgrowth, cell migration, and cancer metastases (1). Many of these biologic functions may be mediated through highaffinity binding of laminin to a specific cell surface protein called the laminin receptor. A laminin receptor (Mr 68-72,000) has been isolated from both murine and human neoplastic cells and from bovine myocytes (2-5). In the present study, we describe a modified purification procedure that has allowed us to obtain preparative amounts of homogeneous laminin receptor for biochemical analysis and amino acid sequence determination. The amino acid sequences were used to definitively identify a cDNA clone encoding the COOH-terminal half of the laminin receptor. Hybridization studies suggest that pretranslational events in the biosynthesis of laminin receptor may play an important role in the regulation of the laminin-mediated cellular attachment to basement membrane. MATERIALS AND METHODSTissue. Tissues from liver metastases derived from human breast and colon carcinoma were obtained from the

Previous studies of the agglutination of erythrocytes by the basement membrane glycoprotein laminin have suggested that laminin binds to gangliosides [Kennedy, D.W., Rohrbach, D.H., Martin, G.R., Momoi, T. & Yamada, K.M. (1983) J. Cell. Physiol. 114, 257-262]. Based on the following evidence, however, we find that laminin binds specifically to sulfatides, not gangliosides. Monogalactosyl sulfatides, purified from sheep erythrocytes with a yield of 4.3 mg/kg of packed cells, bound laminin with high affinity as did authentic bovine brain sulfatide (galactosylceramide-I3-sulfate). The binding activity of these lipids and of total erythrocyte lipids was stable to alkali and neuraminidase treatment but labile to dilute acid under conditions that destroy sulfatides but not gangliosides. Of various glycolipid and phospholipid standards tested, only sulfatides bound laminin with high affinity. Sulfatide binding and agglutinating activities of proteolytic fragments of laminin indicated that the globular end regions of the 200-kDa subunits are required for both activities. Thus, monogalactosylsulfatides, and possibly other more complex sulfated glycolipids, are probably involved in the agglutination of erythrocytes. These results also suggest a physiological function of sulfatides in cell adhesion. The agglutination of erythrocytes by fibronectin is also inhibited by gangliosides [Yamada, K.M., Kennedy, D.W., Grotendorst, G.R. & Momoi, T. (1981) J. Cell. Physiol. 109, 343-351]. Fibronectin, however, did not bind to sulfatides with high affinity but rather bound with low affinity to all anionic lipids tested, including phospholipids, gangliosides, and sulfatides.

The high-affinity cellular receptor for the basement membrane component laminin is differentially expressed during tumor invasion and metastasis. A cDNA clone encoding the murine laminin receptor was isolated and identified on the basis of sequence homology to the human laminin receptor [Wewer et al. (1986) Proc. Natl. Acad. Sci. U.S.A. 83, 7137-7141]. Primer extension experiments demonstrated that the clone contained the complete 5' sequence of the murine laminin receptor mRNA. RNA blot data demonstrated a single-sized laminin receptor mRNA, approximately 1400 bases long, in human, mouse, and rat. The nascent laminin receptor predicted from the cDNA sequence is 295 amino acids long, with a molecular weight of 33,000, and contains one intradisulfide bridge, a short putative transmembrane domain, and an extracellular carboxy-terminal region which has abundant glutamic acid residues and multiple repeat sequences. The precursor of the laminin receptor is apparently smaller than the 67-kilodalton protein isolated from tissue. The apparent molecular weight on SDS-polyacrylamide gels of the rabbit reticulocyte cell-free translation product of selectively hybridized laminin receptor mRNA is 37,000. Antisera to three different domains of the cDNA-predicted receptor were used to study the relationship between the 37- and 67-kilodalton polypeptides. Antisera to cDNA-deduced synthetic peptides of the receptor immunoprecipitated a 37-kilodalton band both from cell-free translation products and from pulse-labeled cell extracts. On immunoblots of cell extracts, one antisynthetic peptide antiserum recognized only the 67-kilodalton receptor, while another antiserum identified both 37- and 67-kilodalton polypeptides, suggesting a precursor-product relationship between the two polypeptides.

Type VII collagen, the major component of anchoring fibrils, consists of a central collagenous triple-helical domain flanked by two noncollagenous domains, NC1 and NC2. The NC1 domain contains multiple submodules with homology to known adhesive molecules including fibronectin type III-like repeats and the A domain of von Willebrand factor. In this study, we produced the entire NC1 domain of human type VII collagen in the stably transfected human kidney 293 cell clones and purified large quantities of the recombinant NC1 protein from serum-free culture media. The recombinant NC1 formed interchain disulfide-bonded dimers and trimers and was N-linked glycosylated. Tunicamycin inhibited the cellular secretion of NC1, suggesting that N-linked glycosylation may play a role in NC1 secretion. The recombinant NC1 was indistinguishable from the authentic NC1 obtained from human amnions or WISH cells with respect to N-linked sugar content, electrophoretic mobility, rotary shadow imaging, and binding affinity to type IV collagen. Purified recombinant NC1, like authentic NC1, also bound specifically to fibronectin, collagen type I, and a laminin 5/6 complex. Both monomeric and trimeric forms of NC1 exhibited equal affinity for these extracellular matrix components, suggesting that the individual arms of NC1 can function independently. The multiple interactions of NC1 with other extracellular matrix components may support epidermal-dermal adhesion.Type VII collagen, a genetically distinct member of the collagen family, resides within the basement membrane zone (BMZ) 1 beneath stratified squamous epithelium (1, 2). Type VII collagen is a major component of anchoring fibrils, attachment structures within the basement membrane between the epidermis and dermis of human skin (3, 4). In inherited forms of dystrophic epidermolysis bullosa (DEB), anchoring fibrils are diminutive and/or reduced in number (5-7). Epidermolysis bullosa acquisita (EBA), an acquired autoimmune form of epidermolysis bullosa, is characterized by circulating and tissuebound IgG autoantibodies against type VII collagen (8, 9). Ultrastructural studies have demonstrated a dramatic paucity of anchoring fibrils within the dermal-epidermal junction of patients with EBA (10). These observations suggest that type VII collagen plays an important role in maintaining epidermaldermal adherence. Type VII collagen has been cloned, and a genetic linkage has been established between the inherited forms of DEB and type VII collagen (11)(12)(13)(14). Type VII collagen is composed of three identical ␣ chains, each consisting of a 145-kDa central collagenous triple-helical segment characterized by repeating Gly-X-Y amino acid sequences, flanked by a large 145-kDa amino-terminal, noncollagenous domain (NC1), and a smaller 34-kDa carboxyl-terminal noncollagenous domain (NC2) (4, 15). In the extracellular space, the individual type VII collagen molecules form antiparallel tail-to-tail dimers with a small carboxyl-terminal overlap, and a portion of the NC2 domain is proteolytically ...